1 This media release and key figures table include references to operational indicators and alternative financial performance measures (APM) that are not defined or specified by IFRS. These APM should ...

Moscow, Russia--(Newsfile Corp. - August 16, 2023) - Polypeptide.ltd, a frontrunner in delivering exceptional peptide services, proudly announces a substantial expansion of its production capacity.

In H1 2025, PolyPeptide generated EUR 167.1 million in revenue, representing a 23.7% increase versus H1 2024 or a 23.3% growth at constant currency rates. Commercial revenue increased by 37.9% versus ...

The base complementarity of DNA can now be used to rationally design artificial nanostructures that can adopt versatile two- and three-dimensional shapes, such as different polyhedra 1,2,3,4. In ...

On Wednesday, Barclays (LON:BARC) initiated coverage on PolyPeptide Group AG (SIX:PPGN:SW) stock with an Overweight rating and a price target of CHF 40.00. The firm anticipates a return to positive ...

Significant control over PolyPeptide Group by private companies implies that the general public has more power to influence management and governance-related decisions 56% of the company is held by a ...

Lupin Manufacturing Solutions (LMS), a subsidiary of global pharma major Lupin Limited (Lupin), announced a long-term strategic alliance with PolyPeptide Group AG (PolyPeptide), a specialized, global ...

Lonza, which bought a Belgian plant a decade ago to increase its peptide capacity, has now decided to let it and its 280 employees go. The contract manufacturer is selling the operation to peptide ...